Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Science 37 Holdings, Inc. - Common Stock (NQ: SNCE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 5.680 (1)
Ask (Size) 5.750 (1)
Prev. Close 5.750
Today's Range N/A - N/A
52wk Range 4.320 - 7.390
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
From Science 37, Inc.
Via GlobeNewswire

Performance

More News

Read More
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
From Science 37, Inc.
Via GlobeNewswire
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
From Science 37, Inc.
Via GlobeNewswire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
From Science 37, Inc.
Via GlobeNewswire
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q1 2023
Via InvestorPlace
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q2 2023
Via InvestorPlace
SNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q3 2023
Via InvestorPlace
Science 37 Receives Top Honors in Everest PEAK Matrix®
From Science 37, Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.